Using the EuroQoI 5-D in the Catalan general population: feasibility and construct validity.
about
Do English and Chinese EQ-5D versions demonstrate measurement equivalence? An exploratory studyValidity of the AusTOM scales: a comparison of the AusTOMs and EuroQol-5DDisease-specific quality of life evaluation and its determinants in Cushing's syndrome: what have we learnt?Social economic costs and health-related quality of life in patients with degenerative cerebellar ataxia in SpainEvaluation of a culturally-adapted lifestyle intervention to treat elevated cardiometabolic risk of Latino adults in primary care (Vida Sana): A randomized controlled trialPredictive factors of severe multilobar pneumonia and shock in patients with influenza.Preventing the onset of major depression based on the level and profile of risk of primary care attendees: protocol of a cluster randomised trial (the predictD-CCRT study).Community pharmacist intervention in depressed primary care patients (PRODEFAR study): randomized controlled trial protocolThe validity and reliability of the Arabic version of the EQ-5D: a study from JordanHealth related quality of life of Canary Island citizens.One-year follow-up of quality of life in adults with untreated growth hormone deficiency.Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease.Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).Health related quality of life in inflammatory bowel disease: the impact of surgical therapyComparing health status in Belarus between 2001-10: a novel method using surveys with different response categories.Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial.Evaluation of health-related quality of life using EQ-5D in Takamatsu, Japan.Health status of the advanced elderly in six European countries: results from a representative survey using EQ-5D and SF-12The quality of life in patients with Crohn's disease.A randomised controlled non-inferiority trial of primary care-based facilitated access to an alcohol reduction website (EFAR Spain): the study protocolCost-effectiveness of a community pharmacist intervention in patients with depression: a randomized controlled trial (PRODEFAR Study).Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients.Cost-effectiveness of active monitoring versus antidepressants for major depression in primary health care: a 12-month non-randomized controlled trial (INFAP study)Long-term outcome and quality of life of patients treated in surgical intensive care: a comparison between sepsis and trauma.Research aimed at improving both mood and weight (RAINBOW) in primary care: A type 1 hybrid design randomized controlled trial.The discriminative power of the EuroQol visual analog scale is sensitive to survey language in SingaporeAssessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare?Medication-related factors associated with health-related quality of life in patients older than 65 years with polypharmacy.Quantification of the level descriptors for the standard EQ-5D three-level system and a five-level version according to two methodsStudy of Patients' Willingness to Pay for a Cure of Chronic Obstructive Pulmonary Disease in Taiwan.Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study.Relationship between the EQ-5D index and measures of clinical outcomes in selected studies of cardiovascular interventions.The use of the EQ-5D preference-based health status measure in adults with Type 2 diabetes mellitus.Quality-of-life loss of people admitted to burn centers, United States.Profiles of sociodemographic, behavioral, clinical and psychosocial characteristics among primary care patients with comorbid obesity and depression.The reliability and validity of the Xhosa version of the EQ-5D.Health-related quality of life in HIV/AIDS patients on antiretroviral therapy at a tertiary care facility in Zimbabwe.Predictors of Change in Dyspnea Level in Acute Exacerbations of COPD.Normative values of EQ-5D-5L: in a Spanish representative population sample from Spanish Health Survey, 2011.Validation of the Short Form of the Brief Pain Inventory (BPI-SF) in Spanish Patients with Non-Cancer-Related Pain.
P2860
Q24798201-E4B99008-40C1-46F6-B274-4459ACFC67AEQ24798962-17290B9F-EE19-4421-923A-DA3066A2EA13Q26865737-8E86063E-A3CB-438E-803F-C3E83256C88FQ28257112-39A1FB80-B63A-40ED-9048-9E4762BB220EQ30385848-48EA19EF-AA28-4A52-88CF-353A24C1BF65Q30427721-1B65F08F-F031-4CCA-8ADF-064D10D201DBQ30541071-E2279E9A-EA0B-49D4-BCF3-EFDCE17729A3Q33490837-FD226C44-4D11-493C-8C5E-407A33F70FB8Q33738296-D489CBD1-08B4-4F8D-845D-51B6BB5C0C21Q33739925-380F6700-788E-47EB-9B8C-622114F15864Q33859242-5E0EF0F5-2BFA-41D5-89E8-AEEDA0650E9FQ33975623-B4BBD187-69F0-4503-8265-DDB1BAFF1A33Q34177200-1AC6E137-2692-4E92-9753-3BFE8E2BE43BQ34246925-4575CE29-7446-4990-8B0C-68D97A2D0667Q34302851-3114B75D-A235-43FA-A63A-EC8580B220A1Q34374726-78D62A77-1BE9-462E-91D4-99640537F43DQ34393829-E6924C76-BFFC-4ECE-9D42-026FD99A7C66Q34437749-AF47348E-F38F-4C8C-9D84-B7625714BAA4Q34799371-C66A9BBB-065E-4347-81AF-B990890703D6Q34799916-1EB443AF-5621-42B0-A32D-E8B630E98596Q34947318-CFD7C0BF-B302-494F-8DC7-F792813DE1B8Q35083972-A1757C9F-AFE2-40E9-8B41-D14D0A05C651Q35380186-B8337AB9-F029-40D4-86C7-D4CCE192F1C0Q35544733-3E00CFAF-D840-4E40-A513-55E0052BB473Q35957450-01C21DAA-0682-4DEC-9D0A-155FB1DC5334Q36003470-8081697E-9B57-4B02-A295-F93E944E17F8Q36200121-7645129E-D973-419F-9B24-BF8B9354FE09Q36271696-6EECE517-88A5-47E0-BA96-CAD6AFDBE6BDQ36509636-1E2651CF-3604-46B2-AD97-74533228DDECQ36732324-00D96029-9F46-49F7-9108-BBE8D116A5F6Q37150150-48ACDAA5-B671-4F87-A1B6-303E47A3358FQ37460598-9FB12DAC-62F6-4D90-A701-57B3488043D8Q37851559-80672226-3352-4C7B-BAD6-DBFDD8A1EBD0Q38066012-F75C73C9-44D2-4381-AD2B-80DF5566B9D9Q38608902-5282121A-5A7E-4BE0-994F-602EE0018EABQ39671272-C149DB76-BD9F-4414-9749-3E37700AF2DAQ39836101-30D205FF-D569-41D5-A666-76140E87D86EQ40211649-6C3E3BFD-287A-4F85-A822-DB56B02CAF38Q40413898-9A947C4B-79CD-488D-AA9E-2B071C162F35Q43424035-7DB15726-7EC3-4279-81A1-ECF59F18D507
P2860
Using the EuroQoI 5-D in the Catalan general population: feasibility and construct validity.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Using the EuroQoI 5-D in the C ...... bility and construct validity.
@en
Using the EuroQoI 5-D in the C ...... bility and construct validity.
@nl
type
label
Using the EuroQoI 5-D in the C ...... bility and construct validity.
@en
Using the EuroQoI 5-D in the C ...... bility and construct validity.
@nl
prefLabel
Using the EuroQoI 5-D in the C ...... bility and construct validity.
@en
Using the EuroQoI 5-D in the C ...... bility and construct validity.
@nl
P2093
P356
P1476
Using the EuroQoI 5-D in the C ...... bility and construct validity.
@en
P2093
P304
P356
10.1023/A:1008894502042
P577
1998-05-01T00:00:00Z